Benzinga - Tue, 06 Apr 2021 10:57:02 -0400
Benzinga - Wed, 31 Mar 2021 08:15:30 -0400
Benzinga - Wed, 31 Mar 2021 07:08:44 -0400
Benzinga - Mon, 29 Mar 2021 17:12:01 -0400
Benzinga - Fri, 26 Mar 2021 07:00:52 -0400
Benzinga - Thu, 25 Mar 2021 11:01:47 -0400
Benzinga - Wed, 24 Mar 2021 05:23:08 -0400
Benzinga - Tue, 23 Mar 2021 14:40:06 -0400
Benzinga - Tue, 23 Mar 2021 12:42:19 -0400
Benzinga - Tue, 23 Mar 2021 12:00:12 -0400
load more
Sector: Health Care.Industry: Biotechnology
Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes a synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactant without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF that is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-13
REV
Q4 2020Est.ActualSurprise
EPS-0.430
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
WINTWindtree Therapeutics-2.85%62.8M

Windtree Therapeutics Company Questions & Answers

Q

How do I buy Windtree Therapeutics (WINT) stock?

A

You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Windtree Therapeutics's (WINT) main competitors?

A

Other companies in Windtree Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Brickell Biotech (NASDAQ:BBI) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

Q

What is the target price for Windtree Therapeutics?

A

The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Ladenburg Thalmann on 2020-06-26. The analyst firm set a price target for 12.25 expecting WINT to rise to within 12 months (a possible 412.55% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Windtree Therapeutics (WINT) stock ?

A

The stock price for Windtree Therapeutics (NASDAQ: WINT) is $2.39 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Windtree Therapeutics (WINT) dividend?

A

There are no upcoming dividends for Windtree Therapeutics.

Q

When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?

A
Windtree Therapeutics’s Q1 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for WINT?

A

There is no upcoming split for Windtree Therapeutics.